Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · LifeMD, Inc. (LFMD)

LifeMD cuts 2026 revenue and adjusted EBITDA guidance after second-quarter loss

Negative Impact 4 of 5 guidance Written later

LifeMD reported second-quarter 2026 revenue of $47.3 million, down from $49.0 million a year earlier, and a net loss of $7.9 million, or $0.16 per share, compared with a $0.09 per share loss a year earlier. The company cut its full-year 2026 revenue guidance to $205.5 million to $212.5 million from $220 million to $230 million, and its adjusted EBITDA guidance to a loss of $6.0 million to breakeven from $12 million to $17 million, which lowers expectations for shareholders.

Key points

  • Q2 2026 revenue was $47.3 million, within the company's $47 million to $50 million guidance range but below $49.0 million a year earlier.
  • Adjusted EBITDA loss was approximately $3.5 million, compared with adjusted EBITDA of approximately $3.9 million in the prior-year quarter.
  • Full-year 2026 revenue guidance was revised to $205.5 million to $212.5 million, from $220 million to $230 million previously.
  • Cash totaled $25.1 million at June 30, 2026, with no debt and an undrawn $30 million revolving credit facility.

The filing

CompanyLifeMD, Inc. (LFMD)
Form8-K, current report
Filed with the SECAug 5, 2026, 4:10 PM ET
Accession number0001493152-26-036170

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.